Picture of Antengene logo

6996 Antengene Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for Antengene, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue0028.816067.3
Cost of Revenue
Gross Profit24.213255
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses3232,928684761648
Operating Profit-323-2,928-655-601-580
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-324-2,929-656-601-581
Provision for Income Taxes
Net Income After Taxes-324-2,929-656-601-581
Net Income Before Extraordinary Items
Net Income-324-2,929-656-601-581
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-324-2,929-656-601-581
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.485-11.6-1.05-0.974-0.945